Report ID: ARS12118 | Category: Healthcare and Pharmaceuticals | Pages: 128 | Format: PDF | Published Date: December 18,2023
Table of Content 1 CRISPR Technology Market Overview 1.1 CRISPR Technology Product Overview 1.1.1 CRISPR Technology Product Scope 1.1.2 CRISPR Technology Market Status and Outlook 1.2 Global CRISPR Technology Market Size Overview by Region 2018 VS 2022VS 2029 1.3 Global CRISPR Technology Market Size by Region (2018-2029) 1.4 Global CRISPR Technology Historic Market Size by Region (2018-2023) 1.5 Global CRISPR Technology Market Size Forecast by Region (2023-2029) 1.6 Key Regions, CRISPR Technology Market Size (2018-2029) 1.6.1 North America CRISPR Technology Market Size (2018-2029) 1.6.2 Europe CRISPR Technology Market Size (2018-2029) 1.6.3 Asia-Pacific CRISPR Technology Market Size (2018-2029) 1.6.4 Latin America CRISPR Technology Market Size (2018-2029) 1.6.5 Middle East & Africa CRISPR Technology Market Size (2018-2029) 2 CRISPR Technology Market Overview by Type 2.3 Global CRISPR Technology Market Size by Type: 2018 VS 2022 VS 2029 2.4 Global CRISPR Technology Historic Market Size by Type (2018-2023) 2.5 Global CRISPR Technology Forecasted Market Size by Type (2023-2029) 2.6 Key Regions Market Size Segment by Type (2018-2029) 2.6.1 North America CRISPR Technology Market Size Breakdown by Type (2018-2029) 2.6.2 Europe CRISPR Technology Market Size Breakdown by Type 2.6.3 Asia-Pacific CRISPR Technology Market Size Breakdown by Type 2.6.4 Latin America CRISPR Technology Market Size Breakdown by Type 2.6.5 Middle East and Africa CRISPR Technology Market Size Breakdown by Type 3 CRISPR Technology Market Overview by Application 3.3 Global CRISPR Technology Market Size by Application: 2018 VS 2022 VS 2029 3.4 Global CRISPR Technology Historic Market Size by Application (2018-2023) 3.5 Global CRISPR Technology Forecasted Market Size by Application (2023-2029) 3.6 Key Regions Market Size Segment by Application (2018-2029) 3.6.1 North America CRISPR Technology Market Size Breakdown by Application (2018-2029) 3.6.2 Europe CRISPR Technology Market Size Breakdown by Application 3.6.3 Asia-Pacific CRISPR Technology Market Size Breakdown by Application 3.6.4 Latin America CRISPR Technology Market Size Breakdown by Application 3.6.5 Middle East and Africa CRISPR Technology Market Size Breakdown by Application 4 CRISPR Technology Competition Analysis by Players 4.1 Global CRISPR Technology Market Size by Players (2018-2023) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CRISPR Technology as of 2022) 4.3 Date of Key Players Enter into CRISPR Technology Market 4.4 Global Top Players CRISPR Technology Headquarters and Area Served 4.5 Key Players CRISPR Technology Product Solution and Service 4.6 Competitive Status 4.6.1 CRISPR Technology Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 North America CRISPR Technology Market Segment by Country 5.1 North America CRISPR Technology Market Size by Country (2018-2029) 5.2 United States 5.3 Canada 6 Europe CRISPR Technology Market Segment by Country 6.1 Europe CRISPR Technology Market Size by Country (2018-2029) 6.2 Germany 6.3 France 6.4 U.K. 6.5 Italy 6.6 Russia 6.7 Nordic 6.8 Rest of Europe 7 Asia-Pacific CRISPR Technology Market Segment by Country 7.1 Asia-Pacific CRISPR Technology Market Size by Region (2018-2029) 7.2 China 7.3 Japan 7.4 South Korea 7.5 Southeast Asia 7.6 India 7.7 Australia 7.8 Rest of Asia-Pacific 8 Latin America CRISPR Technology Market Segment by Country 8.1 Latin America CRISPR Technology Market Size by Country (2018-2029) 8.2 Mexico 8.3 Brazil 8.4 Rest of Latin America 9 Middle East and Africa CRISPR Technology Market Segment by Country 9.1 Middle East & Africa CRISPR Technology Market Size by Country (2018-2029) 9.2 Turkey 9.3 Saudi Arabia 9.4 UAE 9.5 Rest of Middle East & Africa 10 Manufacturers Profiles 10.1 Horizon Discovery Group plc 10.1.1 Horizon Discovery Group plc Information 10.1.2 Business Overview 10.1.3 Horizon Discovery Group plc CRISPR Technology Revenue, Gross Margin 10.1.4 CRISPR Technology Products Offered 10.1.5 Horizon Discovery Group plc Recent Development 10.2 Sangamo Therapeutics 10.2.1 Sangamo Therapeutics Information 10.2.2 Business Overview 10.2.3 Sangamo Therapeutics CRISPR Technology Revenue, Gross Margin 10.2.4 CRISPR Technology Products Offered 10.2.5 Sangamo Therapeutics Recent Development 10.3 GenScript Biotech 10.3.1 GenScript Biotech Information 10.3.2 Business Overview 10.3.3 GenScript Biotech CRISPR Technology Revenue, Gross Margin 10.3.4 CRISPR Technology Products Offered 10.3.5 GenScript Biotech Recent Development 10.4 Integrated DNA Technologies, Inc. 10.4.1 Integrated DNA Technologies, Inc. Information 10.4.2 Business Overview 10.4.3 Integrated DNA Technologies, Inc. CRISPR Technology Revenue, Gross Margin 10.4.4 CRISPR Technology Products Offered 10.4.5 Integrated DNA Technologies, Inc. Recent Development 10.5 Precision Biosciences 10.5.1 Precision Biosciences Information 10.5.2 Business Overview 10.5.3 Precision Biosciences CRISPR Technology Revenue, Gross Margin 10.5.4 CRISPR Technology Products Offered 10.5.5 Precision Biosciences Recent Development 10.6 Beam Therapeutics Inc. 10.6.1 Beam Therapeutics Inc. Information 10.6.2 Business Overview 10.6.3 Beam Therapeutics Inc. CRISPR Technology Revenue, Gross Margin 10.6.4 CRISPR Technology Products Offered 10.6.5 Beam Therapeutics Inc. Recent Development 10.7 Thermo Fisher Scientific Inc. 10.7.1 Thermo Fisher Scientific Inc. Information 10.7.2 Business Overview 10.7.3 Thermo Fisher Scientific Inc. CRISPR Technology Revenue, Gross Margin 10.7.4 CRISPR Technology Products Offered 10.7.5 Thermo Fisher Scientific Inc. Recent Development 10.8 Intellia Therapeutics 10.8.1 Intellia Therapeutics Information 10.8.2 Business Overview 10.8.3 Intellia Therapeutics CRISPR Technology Revenue, Gross Margin 10.8.4 CRISPR Technology Products Offered 10.8.5 Intellia Therapeutics Recent Development 10.9 CRISPR Therapeutics AG 10.9.1 CRISPR Therapeutics AG Information 10.9.2 Business Overview 10.9.3 CRISPR Therapeutics AG CRISPR Technology Revenue, Gross Margin 10.9.4 CRISPR Technology Products Offered 10.9.5 CRISPR Therapeutics AG Recent Development 10.10 Vertex Pharmaceuticals Incorporated 10.10.1 Vertex Pharmaceuticals Incorporated Information 10.10.2 Business Overview 10.10.3 Vertex Pharmaceuticals Incorporated CRISPR Technology Revenue, Gross Margin 10.10.4 CRISPR Technology Products Offered 10.10.5 Vertex Pharmaceuticals Incorporated Recent Development 10.11 New England Biolabs 10.11.1 New England Biolabs Information 10.11.2 Business Overview 10.11.3 New England Biolabs CRISPR Technology Revenue, Gross Margin 10.11.4 CRISPR Technology Products Offered 10.11.5 New England Biolabs Recent Development 10.12 Agilent Technologies, Inc. 10.12.1 Agilent Technologies, Inc. Information 10.12.2 Business Overview 10.12.3 Agilent Technologies, Inc. CRISPR Technology Revenue, Gross Margin 10.12.4 CRISPR Technology Products Offered 10.12.5 Agilent Technologies, Inc. Recent Development 10.13 Merck KGaA 10.13.1 Merck KGaA Information 10.13.2 Business Overview 10.13.3 Merck KGaA CRISPR Technology Revenue, Gross Margin 10.13.4 CRISPR Technology Products Offered 10.13.5 Merck KGaA Recent Development 11 CRISPR Technology Market Dynamics 11.1 CRISPR Technology Industry Trends 11.2 CRISPR Technology Growth Drivers 11.3 CRISPR Technology Market Challenges 11.4 CRISPR Technology Market Restraints 12 Research Findings and Conclusion 13 Methodology and Data Source 13.1 A Methodology 13.1.1 Research Process 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 B Data Source 13.2.1 Legal Disclaimer
It contains all the geographic trends, and market analysis for global market